Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth
Mahindra Manulife Investment Management Private Limited · Direct Plan · Growth
Fund overview
1% on or before 3M, Nil after 3M
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,172 | +172 |
| 3 Years | ₹1,000 | ₹1,609 | +609 |
| 5 Years | ₹1,000 | ₹2,209 | +1,209 |
Calculated using the fund's annualised return since inception (17.2% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
69 securitiesTop 10 holdings make up 25.5% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| ICICI Bank Ltd | Banks | Large Cap | 4.38% |
| Triparty Repo | Cash/Deposits/Margins/Treps/Repo/Swaps | — | 3.47% |
| Zomato Ltd | Retailing | Large Cap | 2.84% |
| Axis Bank Ltd | Banks | Large Cap | 2.81% |
| Federal Bank Ltd | Banks | Mid Cap | 2.76% |
| HDFC Bank Ltd | Banks | Large Cap | 2.71% |
| Glenmark Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 2.36% |
| Senores Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Small Cap | 2.16% |
| Indusind Bank Ltd | Banks | Mid Cap | 2.04% |
| Laurus Labs Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 2.03% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹2,753 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹2,649 Cr
Exit load, stamp duty & tax
30-Dec-19
1% on or before 3M, Nil after 3M
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | 11.54% |
| Beta | 0.95 |
| Sharpe Ratio | 3.43 |
| Sortino Ratio | 0.59 |
| Treynor Ratio | 0.42 |
| Jensen's Alpha | 6.80 |
| Information Ratio | 0.47 |
| R-Squared | 93.12% |
| Max Drawdown | -3.15% |
| Upside Capture | 113.79% |
| Downside Capture | 86.11% |
Fund management
Scheme Details
Investment objective
The Investment Objective Of The Scheme Is To Seek Long Term Capital Growth Through Investments Inequity And Equity Related Securities Of Both Large Cap And Mid Cap Stocks. However, There Can Be Noassurance That The Investment Objective Of The Scheme Will Be Achieved.
Fund house
Mahindra Manulife Investment Management Private Limited
Frequently asked questions
What is the NAV of Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth?
The NAV of Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth is ₹29.44 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth?
The expense ratio charged by Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth is 0.85%.
What is the Min. SIP of Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth?
The minimum SIP investment in Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth is ₹500 per month.
What is the Min. Lumpsum of Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth?
The minimum lumpsum investment in Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth is ₹1,000.
What is the Exit Load of Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth?
The exit load for Mahindra Manulife Large & Mid Cap Fund - Direct Plan -Growth is: 1% on or before 3M, Nil after 3M
.svg){kind=small}